Showing results (1151-1160 of 1,351) with videos related to

Sort By:
Pageof 136
World Journal of Urology|June 23, 2025
Impact of ureteroscopy on renal function in solitary kidneys: a systematic reviewCharles Jaouen, Olivier Traxer, Stefano Moretto, et al.
The French Journal of Urology|October 18, 2025
Updated 2025 French guidelines for renal cell carcinomaPierre Bigot, Zine-Eddine Khene, Romain Boissier, et al.
Minerva Urology and Nephrology|July 13, 2026
Off-clamp and on-clamp robotic-assisted partial nephrectomy in ischemia-sensitive patients: a multicenter propensity score-matched study (RAPN OFF-CLAMP study - UroCCR 187)Léo Schurdi-Levraud, Gaëlle Margue, Arna Geshkovska, et al.
BJU International|April 15, 2025
Investigation of whether renal tumours with caval thrombi induce particular risks: a multicentre study (UroCCR-174 CAVORISK)Adrien Panis, Thibaut Waeckel, Karim Bensalah, et al.
Urologic Oncology|February 14, 2013
Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinomaGéraldine Pignot, Pierre Colin, Marc Zerbib, et al.
European Urology Open Science|May 31, 2022
Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 StudyMagnus Lindskog, Anna Laurell, Anders Kjellman, et al.
Urologic Oncology|November 27, 2024
Delayed partial nephrectomy following complete response to immunotherapy: feasibility and results (UroCCR n°157)Gaëlle Margue, Clément Klein, Bastien Parier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2024
Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven MalignanciesFrancesco Facchinetti, Yohann Loriot, Floriane Brayé, et al.
Clinical Genitourinary Cancer|June 23, 2024
Effect of Treatment of Residual Disease After Immunotherapy-Based Combinations on Complete Response Rate of Patients With Metastatic Renal Cell CarcinomasF Moinard-Butot, M Oriel, T Tricard, et al.
Clinical Genitourinary Cancer|December 31, 2024
A Prospective Non-interventional Real-World Study of cabozantinib in Pretreated Patients With Advanced Renal Cell Carcinoma Refractory to Vascular Endothelial Growth Factor-Targeted Therapy (CASSIOPE)Michael Staehler, Umberto Basso, Jean-Christophe Eymard, et al.
Pageof 136